Sign up to save your podcasts
Or
Share COVID-19 & Oral Oncolytics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
COVID-19 & Oral Oncolytics
On this mini-podcast, we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center
Related Content:
- ACCC COVID-19 Resource Center
- COVID-19 & Oral Oncolytics Transcript
- Oncology Pharmacy Education Network
- Integrating Oral Oncolytics into Pharmacy Practice
- “The Emerging Role of Oral Oncolytics,” by Ali McBride, PharmD, MS, BCOP
- “The Role of the Oral Oncology Nurse Navigator,” by Mary K. Anderson, BSN, RN, OCN, et al.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.
View all episodes
By Association of Community Cancer CentersOn this mini-podcast, we explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Guest: Lauren J. Sanders, PharmD, MTM Oncology Clinical Pharmacist, Oral Antineoplastics Program, The University of Arizona Cancer Center
Related Content:
- ACCC COVID-19 Resource Center
- COVID-19 & Oral Oncolytics Transcript
- Oncology Pharmacy Education Network
- Integrating Oral Oncolytics into Pharmacy Practice
- “The Emerging Role of Oral Oncolytics,” by Ali McBride, PharmD, MS, BCOP
- “The Role of the Oral Oncology Nurse Navigator,” by Mary K. Anderson, BSN, RN, OCN, et al.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.